These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27193296)

  • 21. First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.
    Lassen D; Ennis ZN; Damkier P
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):32-6. PubMed ID: 26435496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective serotonin reuptake inhibitors and congenital heart anomalies: comparative cohort studies of women treated before and during pregnancy and their children.
    Petersen I; Evans SJ; Gilbert R; Marston L; Nazareth I
    J Clin Psychiatry; 2016 Jan; 77(1):e36-42. PubMed ID: 26845280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanonychia induced by venlafaxine hydrochloride.
    Mercuri SR; Paolino G; Mavilia L; Didona D; Brianti P
    G Ital Dermatol Venereol; 2019 Aug; 154(4):495-496. PubMed ID: 29192476
    [No Abstract]   [Full Text] [Related]  

  • 24. Postpartum Hemorrhage and Use of Serotonin Reuptake Inhibitor Antidepressants in Pregnancy.
    Hanley GE; Smolina K; Mintzes B; Oberlander TF; Morgan SG
    Obstet Gynecol; 2016 Mar; 127(3):553-561. PubMed ID: 26855096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitors and risk for major congenital anomalies.
    Malm H; Artama M; Gissler M; Ritvanen A
    Obstet Gynecol; 2011 Jul; 118(1):111-120. PubMed ID: 21646927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
    PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal exposure to SSRIs or SNRIs and the risk of congenital abnormalities in offspring: A systematic review and meta-analysis.
    Huang W; Page RL; Morris T; Ayres S; Ferdinand AO; Sinha S
    PLoS One; 2023; 18(11):e0294996. PubMed ID: 38019759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Case of Unexpected Ecchymosis Associated With a High Dose of Venlafaxine.
    Selçuk M; Selçuk E
    J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):496-498. PubMed ID: 34166259
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
    Kieler H; Artama M; Engeland A; Ericsson O; Furu K; Gissler M; Nielsen RB; Nørgaard M; Stephansson O; Valdimarsdottir U; Zoega H; Haglund B
    BMJ; 2012 Jan; 344():d8012. PubMed ID: 22240235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
    Bérard A; Iessa N; Chaabane S; Muanda FT; Boukhris T; Zhao JP
    Br J Clin Pharmacol; 2016 Apr; 81(4):589-604. PubMed ID: 26613360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association Between Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Autism: A Systematic Review and Meta-Analysis.
    Brown HK; Hussain-Shamsy N; Lunsky Y; Dennis CE; Vigod SN
    J Clin Psychiatry; 2017 Jan; 78(1):e48-e58. PubMed ID: 28129495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
    Grzeskowiak LE; Gilbert AL; Morrison JL
    J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.
    de Abajo FJ; García-Rodríguez LA
    Arch Gen Psychiatry; 2008 Jul; 65(7):795-803. PubMed ID: 18606952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venlafaxine induced QTc interval prolongation in a therapeutic dose.
    Bavle A
    Asian J Psychiatr; 2015 Aug; 16():63-4. PubMed ID: 26187237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin syndrome induced by a combination of venlafaxine and clomipramine. A case report.
    Pinel-Ríos FJ; Peñuelas-Calvo I; Cerezo-Ramírez N; Hamad-Cueto O; García-Casares N
    Actas Esp Psiquiatr; 2016 Sep; 44(5):193-202. PubMed ID: 27644101
    [No Abstract]   [Full Text] [Related]  

  • 39. Delayed Sinus Tachycardia Associated With Venlafaxine Administration: A Unique Case Report and Discussion.
    Osuagwu FC; Bradley R
    J Clin Psychopharmacol; 2019; 39(6):689-690. PubMed ID: 31688406
    [No Abstract]   [Full Text] [Related]  

  • 40. Risks associated with selective serotonin reuptake inhibitors in pregnancy.
    Malm H; Klaukka T; Neuvonen PJ
    Obstet Gynecol; 2005 Dec; 106(6):1289-96. PubMed ID: 16319254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.